April 5, 2023 – Monaghan Medical Corporation and Premier, Inc., announced their agreement to a three-year contract, effective May 1, 2023, creating a partnership between two healthcare industry leaders. Under the terms of the agreement, Monaghan will provide Premier members with respiratory devices in two categories: Respiratory Therapy Medication Delivery devices and Oscillatory Positive Expiratory Pressure/Positive Airway Pressure devices.
The signed agreement recognizes Monaghan’s reputation for both industry leading technology and proven clinical outcomes. Clinical evidence shows that Monaghan medical devices deliver superior patient outcomes. Monaghan’s reputation for gold-standard medical devices aligns with Premier’s desire to drive process efficiencies and value-driven healthcare spending.
Monaghan is a U.S.-based manufacturer based in Plattsburgh, New York. Monaghan and its affiliates are leaders in the development and manufacture of medical devices that improve the quality of life of patients with respiratory diseases like asthma, Cystic Fibrosis, and COPD. Monaghan’s strength lies in product development and mechanical design supported by a world-class Aerosol and Research Laboratory.
During the COVID-19 pandemic, Monaghan was able to respond quickly to fluctuating market demands, primarily because their suppliers are within driving distance from their production facility, which meant a quick response to the changing healthcare needs.